Slingshot members are tracking this event:
FDA Approves Biomarin's (BMRN) Palynziq (pegvaliase-pqpz) Injection for Treatment of Adults with Phenylketonuria (PKU)
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
May 24, 2018
Don’t see a project related to the catalyst you care about?
Related Keywords Pegvaliase-pqpz, Palynziq, Phenylketonuria